| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |